GTF2IRD2
General transcription factor II-I repeat domain-containing protein 2A
Also known as: FLJ37938, GTD2A_HUMAN, GTF2IRD2A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86UP8
- Gene
- GTF2IRD2
- Ensembl
- ENSG00000196275
- Chromosome
- 7
- Canonical length
- 949 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene is one of several closely related genes on chromosome 7 encoding proteins containing helix-loop-helix motifs. These proteins may function as regulators of transcription. The encoded protein is unique in that its C-terminus is derived from CHARLIE8 transposable element sequence. This gene is located in a region of chromosome 7 that is deleted in Williams-Beuren syndrome, and loss of this locus may contribute to the cognitive phenotypes observed in this disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
949 residues, UniProt reviewed canonical sequence.
>Q86UP8|GTF2IRD2
1 MAQVAVSTLP VEEESSSETR MVVTFLVSAL ESMCKELAKS KAEVACIAVY ETDVFVVGTE
61 RGCAFVNART DFQKDFAKYC VAEGLCEVKP PCPVNGMQVH SGETEILRKA VEDYFCFCYG
121 KALGTTVMVP VPYEKMLRDQ SAVVVQGLPE GVAFQHPENY DLATLKWILE NKAGISFIIN
181 RPFLGPESQL GGPGMVTDAE RSIVSPSESC GPINVKTEPM EDSGISLKAE AVSVKKESED
241 PNYYQYNMQG SHPSSTSNEV IEMELPMEDS TPLVPSEEPN EDPEAEVKIE GNTNSSSVTN
301 SAAGVEDLNI VQVTVPDNEK ERLSSIEKIK QLREQVNDLF SRKFGEAIGV DFPVKVPYRK
361 ITFNPGCVVI DGMPPGVVFK APGYLEISSM RRILEAAEFI KFTVIRPLPG LELSNVGKRK
421 IDQEGRVFQE KWERAYFFVE VQNIPTCLIC KQSMSVSKEY NLRRHYQTNH SKHYDQYMER
481 MRDEKLHELK KGLRKYLLGS SDTECPEQKQ VFANPSPTQK SPVQPVEDLA GNLWEKLREK
541 IRSFVAYSIA IDEITDINNT TQLAIFIRGV DENFDVSEEL LDTVPMTGTK SGNEIFSRVE
601 KSLKNFCIDW SKLVSVASTG TPAMVDANNG LVTKLKSRVA TFCKGAELKS ICCIIHPESL
661 CAQKLKMDHV MDVVVKSVNW ICSRGLNHSE FTTLLYELDS QYGSLLYYTE IKWLSRGLVL
721 KRFFESLEEI DSFMSSRGKP LPQLSSIDWI RDLAFLVDMT MHLNALNISL QGHSQIVTQM
781 YDLIRAFLAK LCLWETHLTR NNLAHFPTLK LASRNESDGL NYIPKIAELQ TEFQKRLSDF
841 KLYESELTLF SSPFSTKIDS VHEELQMEVI DLQCNTVLKT KYDKVGIPEF YKYLWGSYPK
901 YKHHCAKILS MFGSTYICEQ LFSIMKLSKT KYCSQLKDSQ WDSVLHIATLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GTF2IRD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 29 nTPM
- ovary: 17 nTPM
- heart muscle: 17 nTPM
- liver: 16 nTPM
- cervix: 15 nTPM
- colon: 15 nTPM
Single-cell type
- renal collecting duct intercalated cells: 55 nCPM
- distal convoluted tubule cells: 52 nCPM
- renal connecting tubule cells: 43 nCPM
- loop of henle epithelial cells: 41 nCPM
- choroid plexus epithelial cells: 40 nCPM
- renal collecting duct principal cells: 39 nCPM
Immune cell
- memory B-cell: 18 nTPM
- plasmacytoid DC: 12 nTPM
- basophil: 12 nTPM
- naive B-cell: 11 nTPM
- memory CD8 T-cell: 8.7 nTPM
- naive CD4 T-cell: 7.9 nTPM
Brain region
- white matter: 9.1 nTPM
- hypothalamus: 7.5 nTPM
- midbrain: 7.2 nTPM
- thalamus: 7.2 nTPM
- cerebellum: 7 nTPM
- cerebral cortex: 7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GTF2IRD2 as an antibody target. Whether an autoantibody or antibody against GTF2IRD2 could matter depends on whether native GTF2IRD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GTF2IRD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GTF2IRD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...